← FDA DRUG APPROVALS

FDA NDA · NDA019795

CONDYLOX

Sponsor: TEVA BRANDED PHARM

APPLICATION
NDA019795
TYPE
NDA
ORIGINAL APPROVAL
1990-12-13
LATEST ACTION
2015-10-30
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CONDYLOX · ReferenceDiscontinued
PODOFILOX 0.5% · SOLUTION · TOPICAL

Approval history

2015-10-30Manufacturing (CMC) · Supplement 14 · priorityAP
2015-09-10Manufacturing (CMC) · Supplement 15 · priorityAP
2014-01-17Manufacturing (CMC) · Supplement 12 · priorityAP
2013-05-23Manufacturing (CMC) · Supplement 13 · priorityAP
1995-06-28Manufacturing (CMC) · Supplement 7 · priorityAP
1995-05-01Manufacturing (CMC) · Supplement 6 · priorityAP
1994-01-07Manufacturing (CMC) · Supplement 5 · priorityAP
1993-11-03Manufacturing (CMC) · Supplement 4 · priorityAP
1993-08-03Manufacturing (CMC) · Supplement 3 · priorityAP
1991-11-08Manufacturing (CMC) · Supplement 1 · priorityAP
1990-12-13Type 3 - New Dosage Form · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →